(POET) POET Technologies - Overview
Stock: Photonic Interposer, Optical Engine, Integrated Circuits
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 139% |
| Relative Tail Risk | -25.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.62 |
| Alpha | -9.86 |
| Character TTM | |
|---|---|
| Beta | 1.946 |
| Beta Downside | 1.365 |
| Drawdowns 3y | |
|---|---|
| Max DD | 85.87% |
| CAGR/Max DD | 0.11 |
Description: POET POET Technologies December 31, 2025
POET Technologies Inc. (NASDAQ: POET) designs, develops, manufactures, and sells photonic-integrated semiconductor solutions, leveraging its proprietary POET Optical Interposer to co-package electronic and photonic components on a single wafer. The company targets data-center, telecom (including 5G PON/GPON), edge-computing, LIDAR, medical OCT, and VR/light-source markets across the U.S., Canada, Singapore, and China.
Recent filings show POET generated roughly $45 million in revenue in FY 2023, a year-over-year increase of about 12%, driven primarily by expanding data-center interconnect orders. The photonic-interposer market is projected to grow at a 15% CAGR through 2029, with demand for high-bandwidth, low-latency links in 5G rollout and AI-accelerated workloads serving as key macro drivers. POET’s R&D spend remains near 20% of revenue, reflecting the capital-intensive nature of wafer-level photonic integration and the ongoing shortage of dedicated silicon-photonic foundry capacity.
For a deeper quantitative view, you might explore POET’s profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income: -50.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.33 > 0.02 and ΔFCF/TA 8.03 > 1.0 |
| NWC/Revenue: 6939 % < 20% (prev 19.7k%; Δ -12.7k% < -1%) |
| CFO/TA -0.26 > 3% & CFO -28.2m > Net Income -50.6m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (89.8m) vs 12m ago 37.82% < -2% |
| Gross Margin: -77.71% > 18% (prev -11.81%; Δ -6590 % > 0.5%) |
| Asset Turnover: 0.96% > 50% (prev 0.24%; Δ 0.73% > 0%) |
| Interest Coverage Ratio: -158.8 > 6 (EBITDA TTM -17.8m / Interest Expense TTM 127.2k) |
Altman Z'' -7.11
| A: 0.49 (Total Current Assets 93.7m - Total Current Liabilities 40.8m) / Total Assets 107.8m |
| B: -2.70 (Retained Earnings -291.3m / Total Assets 107.8m) |
| C: -0.26 (EBIT TTM -20.2m / Avg Total Assets 79.2m) |
| D: 0.18 (Book Value of Equity 7.46m / Total Liabilities 41.4m) |
| Altman-Z'' Score: -7.11 = D |
Beneish M -0.38
| DSRI: 0.04 (Receivables 125.1k/461.4k, Revenue 762.7k/119.9k) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.67 (AQ_t 0.01 / AQ_t-1 0.01) |
| SGI: 6.36 (Revenue 762.7k / 119.9k) |
| TATA: -0.21 (NI -50.6m - CFO -28.2m) / TA 107.8m) |
| Beneish M-Score: -0.38 (Cap -4..+1) = D |
What is the price of POET shares?
Over the past week, the price has changed by +0.51%, over one month by -19.37%, over three months by +11.17% and over the past year by +14.20%.
Is POET a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the POET price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 6.9 | 18.1% |
| Analysts Target Price | 6.9 | 18.1% |
| ValueRay Target Price | 6.2 | 6.1% |
POET Fundamental Data Overview February 09, 2026
P/B = 13.4925
Revenue TTM = 762.7k USD
EBIT TTM = -20.2m USD
EBITDA TTM = -17.8m USD
Long Term Debt = 784.1k USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 6.65m USD (from shortTermDebt, last quarter)
Debt = 7.28m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -6.23m USD (from netDebt column, last quarter)
Enterprise Value = 811.0m USD (896.4m + Debt 7.28m - CCE 92.7m)
Interest Coverage Ratio = -158.8 (Ebit TTM -20.2m / Interest Expense TTM 127.2k)
EV/FCF = -23.04x (Enterprise Value 811.0m / FCF TTM -35.2m)
FCF Yield = -4.34% (FCF TTM -35.2m / Enterprise Value 811.0m)
FCF Margin = -4615 % (FCF TTM -35.2m / Revenue TTM 762.7k)
Net Margin = -6628 % (Net Income TTM -50.6m / Revenue TTM 762.7k)
Gross Margin = -77.71% ((Revenue TTM 762.7k - Cost of Revenue TTM 1.36m) / Revenue TTM)
Gross Margin QoQ = -199.1% (prev none%)
Tobins Q-Ratio = 7.52 (Enterprise Value 811.0m / Total Assets 107.8m)
Interest Expense / Debt = 0.43% (Interest Expense 31.4k / Debt 7.28m)
Taxrate = 21.0% (US default 21%)
NOPAT = -16.0m (EBIT -20.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.30 (Total Current Assets 93.7m / Total Current Liabilities 40.8m)
Debt / Equity = 0.11 (Debt 7.28m / totalStockholderEquity, last quarter 66.4m)
Debt / EBITDA = 0.35 (negative EBITDA) (Net Debt -6.23m / EBITDA -17.8m)
Debt / FCF = 0.18 (negative FCF - burning cash) (Net Debt -6.23m / FCF TTM -35.2m)
Total Stockholder Equity = 42.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -63.85% (Net Income -50.6m / Total Assets 107.8m)
RoE = -119.7% (Net Income TTM -50.6m / Total Stockholder Equity 42.2m)
RoCE = -46.95% (EBIT -20.2m / Capital Employed (Equity 42.2m + L.T.Debt 784.1k))
RoIC = -32.74% (negative operating profit) (NOPAT -16.0m / Invested Capital 48.7m)
WACC = 12.98% (E(896.4m)/V(903.7m) * Re(13.08%) + D(7.28m)/V(903.7m) * Rd(0.43%) * (1-Tc(0.21)))
Discount Rate = 13.08% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 46.10%
Fair Price DCF = unknown (Cash Flow -35.2m)
EPS Correlation: -0.69 | EPS CAGR: 10.76% | SUE: 0.51 | # QB: 0
Revenue Correlation: 25.25 | Revenue CAGR: 127.5% | SUE: -1.89 | # QB: 0
EPS next Year (2026-12-31): EPS=-0.19 | Chg30d=+0.070 | Revisions Net=-1 | Growth EPS=+34.5% | Growth Revenue=+710.6%